Public Buy-In Of Personalized Medicine Requires Dialogue – Tufts’ Kaitin
Executive Summary
Improving the general public's understanding of drug development and delivery will be necessary to fully leverage the potential of personalized medicine, Tufts Center for the Study of Drug Development Director Kenneth Kaitin said